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Renin is an unique aspartyl (acid) protease with optimal activity at neutral pH. It has been suggested that Ala-317 of 
human renin contributes to neutral optimum pH of the enzyme [(1984) FEBS Lett. 174, 102-l 1 I]. The hypothesis was 
verified by the characterization of mutant renin in which Ala-317 was replaced with Asp by a site-directed mutagenesis. 
Wild-type and mutant renins, which were expressed in COS cells, exhibited different pH-activity profiles and optimum 
pH of the mutant enzyme was lower than that of the wild-type enzyme. This result suggests that Ala-317 of human renin 
plays an important role in the determination of optimum pH of the enzyme. 
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1. INTRODUCTION 
Renin is an aspartyl protease with two 
catalytically important aspartic acid residues. This 
enzyme has unique characteristics in substrate 
specificity, optimum pH and physiological func- 
tion among aspartyl proteases [2]. First, renin acts 
on only angiotensinogen to generate angiotensin I
(AI), whereas other aspartyl proteases digest many 
protein substrates. Second, optimum pH of renin 
is neutral (pH 5.5-7.5), but those of other aspartyl 
proteases are acidic (pH 2.0-4.0). 
From the alignment of amino acid sequences of 
renin and other aspartyl proteases, it has been sug- 
gested that Ala-3 17 of the human renin contributes 
a high optimum pH to the enzyme [l]. The alanine 
residue is commonly found in human [3], mouse 
[4] and rat [5] renin sequences, whereas in other 
aspartyl proteases the corresponding residue is 
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substituted with aspartic acid (fig.1). As Ala-317 
of the human renin is close to the catalytically im- 
portant aspartic acid residues [l], it may affect the 
pKII of the aspartic acid residues and contribute to 
the unique optimum pH. The hypothesis was 
verified by the characterization of Asp-3 17 mutant 
renin expressed in COS cells. 
2. MATERIALS AND METHODS 
Human renin cDNA [3] was subcloned into pUC119 [13] and 
single-stranded DNA was prepared as described [13]. Site- 
directed mutagenesis was performed by the method of Sims et 
al. [14] using the single-stranded DNA as a template. DNA se- 
quence of the mutated cDNA was determined to verify that only 
the desired mutation occurred. Wild-type human renin cDNA 
in pSVDPRnPA33 [15] was replaced with the mutated cDNA to 
generate plasmid pAD317SV in which the codon for Ala-317 
was replaced with an Asp codon. pSVARn was constructed by 
blunt-end ligation of a 5.2 kb AvaI/EcoRV fragment from 
pSVDPRnPA33. COS-7 cells were transfected with the plasmid 
by the DEAE-dextran method with chloroquine treatment [16]. 
Transfected cells were cultured in serum-free Dulbecco’s 
modified Eagle’s medium. 
Partially purified human renal renin was obtained by the 
method of Haas et al. [17]. Hog angiotensinogen was purified 
as described [18]. Renin activity was determined by radioim- 
munoassay of AI generated uring the enzymatic reaction [18]. 
Renin concentration was measured by using a Renin RIA 
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Pasteur kit purchased from Diagnostics Pasteur. Anti-renin an- 
tiserum was obtained from a rabbit immunized with recombi- 
nant human renin from CHO cells [15], which was kindly 
supplied by The Upjohn Company. SDS-PAGE was performed 
by the method of Laemmli [19] and Western blot analysis ,was 
carried out as described [20]. 
3. RESULTS AND DISCUSSION 
COS-7 cells were transfected with the respective 
expression plasmid for wild-type renin 
(pSVDPRnPA33), a mutant renin (pAD317SV) or 
negative control (pSVARn) and cultured at 37°C 
for 72 h. Conditioned medium of the transfected 
cells (COS-CM) was assayed for renin activity us- 
ing hog angiotensinogen as substrate (table 1). 
COS-CM from the cells transfected with the wild- 
type or mutant plasmid showed a very low level of 
activity without activation. However, with tryp- 
sinization under mild conditions renin activity in- 
creased about 50-fold. A similar level of activity 
was detected when the COS-CM was dialysed 
against acidic buffer. The acid activation was a 
reversible process, because the observed activity 
disappeared by dialysis against neutral buffer and 
recovered by redialysis against acidic buffer (not 
shown). This is characteristic for human prorenin 
found in human plasma or expressed in CHO cells 
[21]. Renin activity in the activated COS-CM from 
the cells transfected with the wild-type plasmid was 
about 3-fold higher than that of mutant plasmid 
(table 1). Cells transfected with pSVARn, a 
plasmid lacking most of the renin coding sequence, 
did not express renin activity (table 1). 
Western blot analysis (fig.2) showed that COS- 
CM from the cells transfected with the wild-type 
(lane 3) or mutant (lane 5) plasmid gave a single 
protein band specific for anti-renin antiserum with 
a molecular mass of 46 kDa, which was in good 
agreement with the reported value for human pro- 
renin [21]. Digestion with trypsin decreased the 
size of the protein to 43 kDa (lanes 2,4), a similar 
value to that observed in human mature renin [22]. 
These results indicate that the transfected COS 
cells produced prorenin which was converted to 
mature renin with trypsin, as reported for 
transfected CHO cells [15,21]. 
Activity of wild-type or mutant renin expressed 
in trypsinized COS-CM was measured at various 
pH values to evaluate the effect of the Ala to Asp 
conversion at the 317 residue on the pH- 
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Human renin GPTWALGATFIRKFV 
Mouse renin GPVWVLGATFlRKFV 
Rat renin GPVWVLGATFIRKFV 
Human pepsin GELWILGDVFIRDVF 
Porcine pepsin GELWlLGDVFlROVV 
Penicillopepsin G-FSIFGDIFLKSCJV 
Endothiapepsin G-LLIFGDIFIKASV 
Human cathepsin 0 GPLWILGOVFIGRVY 
Porcine cathepsin 0 GPLWILGD’JFIGRYY 
Bovine chymosin I -OKWILGDVFIREYY 
Fig. 1, Comparison of amino acid sequences of renins and other 
aspartyl proteases. Partial ammo acid sequences containing 
Ala-317 of human [3], mouse [4] and rat [S] renin were aligned 
to the corresponding sequence of human pepsin [6], porcine 
pepsin [7], penicillopepsin [S], endothiapepsin [9], human 
cathepsin D [l l] and bovine chymosin (121. The numbering is 
based on the human mature renin sequence. Dashes show gaps 
introduced to obtain maximal homology. The amino acid 
residues corresponding to Ala-317 of human renin are enclosed. 
dependence of enzyme activity. Using hog 
angiotensinogen as substrate, the pH-dependence 
profile of wild-type renin activity was identical to 
that of human renal renin (fig.3). In contrast, the 
optimum pH of mutant renin definitely shifted by 
0.5 unit to the acidic side. This result indicated that 
wild-type renin expressed in COS cells was essen- 
tially identical to human renal renin in pH 
dependency and the substitution of Ala-317 with 
Table 1 
Renin activity in conditioned medium of the transfected COS 
cells 
Transfected 
plasmid 
Renin activity (ng AI/ml per h) 
Untreated Trypsin- Acid- 
activated activated 
pSVDPRnPA33 
(wild-type) 1.4 71.4 82.9 
pAD3 17SV 
(Asp-3 17 mutant) <OS 24.9 28.4 
pSVARn 
(negative control) <OS <OS ND 
Conditioned medium of COS cells transfected with each 
plasmid was assayed for renin activity before and after 
activation. Pro-renin was activated by trypsin in the 
concentration of 10 /g/ml at 0°C for 30 min or by dialysis at 
4°C for 18 h against 0.1 M citric acid/O.2 M NazHP04 (pH 
3.4). Renin activity was measured at pH 6.5 using hog 
angiotensinogen as substrate. ND, not determined 
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Fig.2. Western blot analysis of proteins expressed in COS-CM. 
developed with horseradish peroxidase. 
COS-CM from the cells transfected with pSVDPRnPA33 (lanes 
2,3), pAD317SV (lanes 4,5) or pSVARn (lane 1) was 
concentrated 24-fold by ultrafiltration. The COS-CMs were 
subjected to SDS-PAGE before (lanes 1,3,5) or after (lanes 2,4) 
incubation with trypsin. Proteins were transferred to 
nitrocellulose filters, incubated with anti-renin antiserum, and 
Asp lowered the optimum pH of the enzyme. The 
observed pH shift to acidic side is probably due to 
the negative charge of Asp-317 introduced into 
mutant renin, which can interact directly or in- 
directly with carboxyl group(s) of catalytically ac- 
tive aspartic acid residues. This 0.5 unit of pH shift 
is definite but smaller than expected. There may be 
two explanations about this smaller pH shift. One 
explanation is that (an)other amino acid residue(s) 
of renin which is (are) not examined in this study, 
may also contribute to its neutral optimum pH. 
Another possibility is that the optimum pH of 
another aspartyl protease such as pepsin and 
cathepsin D on angiotensinogen may be more 
neutral than we assumed. Although direct evidence 
is not available in the present study, the latter 
possibility may be assumed by the previous results 
that the optimum pH values of aspartyl proteases 
depend on substrate [2,23]. Further studies are 
needed to clarify the reason why renin has a 
neutral optimum pH. 
In addition to the pH shift, mutant renin had a 
lower specific activity. The specific activity of 
wild-type and mutant renin in trypsinized COS- 
CMs was 13.9 and 7.1 mg AI/h per mg renin, 
respectively, using a direct radioimmunoassay to 
determine the renin concentration. However, this 
result must be confirmed on purified mutant renin 
4 5 6 7 8 9 
PH 
6.0-8.0 and 0.2 M Tris-HCl for pH 7.5-9.0. 
Fig.3. pH-dependence of renin activity with hog 
angiotensinogen. Activity of wild-type (O---O) or mutant 
(M) renin was measured at the indicated pH using partially 
purified hog angiotensinogen. Human renal renin (A---A) was 
used as a control. Buffers used were: 0.1 M citric acid/O.2 M 
NazHP04 for pH 4.0-6.5, 0.2 M sodium phosphate for pH 
expressed in other systems such as CHO cells 
which are favorable for obtaining milligram quan- 
tities of protein. 
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